Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1964 1
1966 1
1978 1
1979 4
1980 1
1981 1
1982 1
1986 1
1987 1
1988 1
1995 1
2010 2
2011 2
2012 1
2014 2
2015 2
2016 1
2017 1
2018 1
2019 1
2020 1
2021 4
2022 1
2023 1
2024 1
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

29 results

Results by year

Filters applied: . Clear all
Page 1
A Randomized Trial of a Transglutaminase 2 Inhibitor for Celiac Disease.
Schuppan D, Mäki M, Lundin KEA, Isola J, Friesing-Sosnik T, Taavela J, Popp A, Koskenpato J, Langhorst J, Hovde Ø, Lähdeaho ML, Fusco S, Schumann M, Török HP, Kupcinskas J, Zopf Y, Lohse AW, Scheinin M, Kull K, Biedermann L, Byrnes V, Stallmach A, Jahnsen J, Zeitz J, Mohrbacher R, Greinwald R; CEC-3 Trial Group. Schuppan D, et al. Among authors: mohrbacher r. N Engl J Med. 2021 Jul 1;385(1):35-45. doi: 10.1056/NEJMoa2032441. N Engl J Med. 2021. PMID: 34192430 Free article. Clinical Trial.
Transcriptomic analysis of intestine following administration of a transglutaminase 2 inhibitor to prevent gluten-induced intestinal damage in celiac disease.
Dotsenko V, Tewes B, Hils M, Pasternack R, Isola J, Taavela J, Popp A, Sarin J, Huhtala H, Hiltunen P, Zimmermann T, Mohrbacher R, Greinwald R, Lundin KEA, Schuppan D, Mäki M, Viiri K; CEC-3 Investigators. Dotsenko V, et al. Among authors: mohrbacher r. Nat Immunol. 2024 Jul;25(7):1218-1230. doi: 10.1038/s41590-024-01867-0. Epub 2024 Jun 24. Nat Immunol. 2024. PMID: 38914866 Free PMC article. Clinical Trial.
The Oral Transglutaminase 2 Inhibitor ZED1227 Accumulates in the Villous Enterocytes in Celiac Disease Patients during Gluten Challenge and Drug Treatment.
Isola J, Mäki M, Hils M, Pasternack R, Viiri K, Dotsenko V, Montonen T, Zimmermann T, Mohrbacher R, Greinwald R, Schuppan D. Isola J, et al. Among authors: mohrbacher r. Int J Mol Sci. 2023 Jun 28;24(13):10815. doi: 10.3390/ijms241310815. Int J Mol Sci. 2023. PMID: 37445994 Free PMC article. Clinical Trial.
SELECTIVE RAT TOXICANT.
ROSZKOWSKI AP, POOS GI, MOHRBACHER RJ. ROSZKOWSKI AP, et al. Among authors: mohrbacher rj. Science. 1964 Apr 24;144(3617):412-3. doi: 10.1126/science.144.3617.412. Science. 1964. PMID: 14169328
Challenges and Opportunities in IBD Clinical Trial Design.
Dubinsky MC, Collins R, Abreu MT; International Organization for the Study of Inflammatory Bowel Diseases (IOIBD). Dubinsky MC, et al. Gastroenterology. 2021 Aug;161(2):400-404. doi: 10.1053/j.gastro.2021.03.065. Epub 2021 Apr 20. Gastroenterology. 2021. PMID: 33864796 Free article. No abstract available.
Novel Budesonide Suppository and Standard Budesonide Rectal Foam Induce High Rates of Clinical Remission and Mucosal Healing in Active Ulcerative Proctitis: a Randomised, Controlled, Non-inferiority Trial.
Kruis W, Siegmund B, Lesniakowski K, Simanenkov V, Khimion L, Sobon M, Delmans G, Maksyashina SV, Sablin OA, Pokrotnieks J, Mostovoy Y, Datsenko O, Abdulkhakov S, Dorofeyev A, Levchenko O, Alexeeva O, Andreev P, Kolesnik IP, Mihaly E, Abrahamovych O, Baluta M, Kharchenko N, Viacheslav N, Uspenskiy Y, Vieth M, Mohrbacher R, Mueller R, Greinwald R. Kruis W, et al. Among authors: mohrbacher r. J Crohns Colitis. 2022 Nov 23;16(11):1714-1724. doi: 10.1093/ecco-jcc/jjac081. J Crohns Colitis. 2022. PMID: 35709376 Free PMC article. Clinical Trial.
Smoking Status Influences Clinical Outcome in Collagenous Colitis.
Münch A, Tysk C, Bohr J, Madisch A, Bonderup OK, Mohrbacher R, Mueller R, Greinwald R, Ström M, Miehlke S. Münch A, et al. Among authors: mohrbacher r. J Crohns Colitis. 2016 Apr;10(4):449-54. doi: 10.1093/ecco-jcc/jjv235. Epub 2015 Dec 30. J Crohns Colitis. 2016. PMID: 26721941 Free PMC article. Clinical Trial.
2-Tetradecylglycidic acid.
Tutwiler GF, Ho W, Mohrbacher RJ. Tutwiler GF, et al. Among authors: mohrbacher rj. Methods Enzymol. 1981;72:533-51. doi: 10.1016/s0076-6879(81)72042-1. Methods Enzymol. 1981. PMID: 7311851 No abstract available.
Budesonide as induction therapy for incomplete microscopic colitis: A randomised, placebo-controlled multicentre trial.
Münch A, Mihaly E, Nagy F, Madisch A, Kupčinskas J, Miehlke S, Bohr J, Bouma G, Guardiola J, Belloc B, Shi C, Aust D, Mohrbacher R, Greinwald R, Munck LK. Münch A, et al. Among authors: mohrbacher r. United European Gastroenterol J. 2021 Sep;9(7):837-847. doi: 10.1002/ueg2.12131. Epub 2021 Aug 20. United European Gastroenterol J. 2021. PMID: 34414678 Free PMC article. Clinical Trial.
Distribution of histopathological features along the colon in microscopic colitis.
Fiehn AK, Miehlke S, Aust D, Vieth M, Bonderup O, Fernández-Bañares F, Mihaly E, Kupcinskas J, Madisch A, Munck LK, Nacak T, Mohrbacher R, Mueller R, Greinwald R, Münch A. Fiehn AK, et al. Among authors: mohrbacher r. Int J Colorectal Dis. 2021 Jan;36(1):151-159. doi: 10.1007/s00384-020-03747-z. Epub 2020 Sep 12. Int J Colorectal Dis. 2021. PMID: 32920702
29 results